新規登録 | ログイン | FAQ      [?] 

タグ: acei [86 articles]

Recent papers classified by the tag acei.
  • Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension.
    Ann Intern Med (5 November 2007)
    by David B B Matchar, Douglas C C McCrory, Lori A A Orlando, Manesh R R Patel, Uptal D D Patel, Meenal B B Patwardhan, Benjamin Powers, Gregory P P Samsa, Rebecca N N Gray
    posted to acei arb bp by jyuh on 2007-11-09 02:35:23 as **
  • Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 9, No. 6-7. (l 2007), pp. 602-609.
    posted to acei arb chf gender by jyuh on 2008-07-21 03:13:15 as **
  • Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Clinical journal of the American Society of Nephrology : CJASN, Vol. 2, No. 3. (May 2007), pp. 461-469.
    posted to acei dn proteinuria by jyuh on 2008-06-16 05:32:42 as **
  • Progression risk, urinary protein excretion, and treatment effects of Angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.
    J Am Soc Nephrol, Vol. 18, No. 6. (June 2007), pp. 1959-1965.
    by DM Kent, TH Jafar, RA Hayward, H Tighiouart, M Landa, P de Jong, D de Zeeuw, G Remuzzi, AL Kamper, AS Levey
    posted to acei ckd proteinuria by jyuh on 2007-07-19 05:04:55 as **
  • Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
    Postgraduate medicine, Vol. 120, No. 1. (April 2008), pp. 33-42.
    by GL Bakris, MR Weir
    posted to acei arb ckd dual by jyuh on 2008-07-20 15:17:06 as **
  • Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy.
    Vascular health and risk management, Vol. 4, No. 1. (2008), pp. 223-234.
    posted to acei arb cost-effective dual rct by jyuh on 2008-07-21 04:19:24 as **
  • Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the BENEDICT Trial
    J Am Soc Nephrol, Vol. 17, No. 12. (1 December 2006), pp. 3472-3481.
    by Piero Ruggenenti, Annalisa Perna, Maria Ganeva, Bogdan Ene-Iordache, Giuseppe Remuzzi, For
    posted to acei dn proteinuria rct bp by jyuh on 2008-06-14 07:30:28 as **
  • Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.
    Am J Kidney Dis, Vol. 48, No. 1. (July 2006), pp. 8-20.
    by M MacKinnon, S Shurraw, A Akbari, GA Knoll, J Jaffey, HD Clark
    posted to acei arb ckd proteinuria by jyuh on 2007-07-19 05:33:05 as ** along with 1 person timsenior
  • Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, Vol. 27, No. 4. (g 2007), pp. 446-453.
    posted to acei arb pd by jyuh on 2008-04-17 10:27:43 as **
  • Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 22, No. 12. (December 2007), pp. 3573-3579.
    posted to acei cv hd by jyuh on 2008-07-04 14:28:21 as **
  • Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
    American journal of physiology. Renal physiology, Vol. 284, No. 4. (April 2003)
    by R Agarwal
    posted to acei arb ckd inflammation ros by jyuh on 2008-07-08 04:19:33 as **
  • Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
    Journal of hypertension, Vol. 25, No. 10. (October 2007), pp. 2082-2092.
    by V Bhatnagar, DT O'Connor, NJ Schork, RM Salem, CM Nievergelt, BK Rana, DW Smith, GL Bakris, JP Middleton, KC Norris, JT Wright, D Cheek, L Hiremath, G Contreras, LJ Appel, MS Lipkowitz
    posted to ace acei bp snp by jyuh on 2008-08-16 07:54:33 as **
  • Soluble adhesion molecules in end-stage renal disease: a predictor of outcome.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 21, No. 6. (June 2006), pp. 1603-1610.
    posted to acei hd inflammation by jyuh on 2008-07-05 10:48:34 as **
  • Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Journal of hypertension, Vol. 26, No. 7. (July 2008), pp. 1282-1289.
    by Gianpaolo Reboldi, Fabio Angeli, Claudio Cavallini, Giorgio Gentile, Giuseppe Mancia, Paolo Verdecchia
    posted to acei arb cv meta-analysis mortality stroke by jyuh on 2008-07-21 01:49:35 as **
  • Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial
    CMAJ, Vol. 177, No. 8. (9 October 2007), pp. 867-874.
    by Deepa Sumukadas, Miles D Witham, Allan D Struthers, Marion E Mcmurdo
    posted to acei geriatric sarcopenia by jyuh on 2008-06-29 01:12:00 as **
  • Ace inhibitors as a therapy for sarcopenia - evidence and possible mechanisms.
    The journal of nutrition, health & aging, Vol. 12, No. 7. (July 2008), pp. 480-485.
    posted to acei cachexia by jyuh on 2008-07-21 01:48:30 as **
  • ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental Diabetes
    Diabetes, Vol. 57, No. 4. (1 April 2008), pp. 1018-1025.
    by Chris Tikellis, Katarzyna Bialkowski, Josepha Pete, Karen Sheehy, Qui Su, Colin Johnston, Mark E Cooper, Merlin C Thomas
    posted to ace2 acei dn knockout by jyuh on 2008-03-31 11:19:36 as **
  • Sarcopenia--a potential target for Angiotensin-converting enzyme inhibition?
    Gerontology, Vol. 52, No. 4. (2006), pp. 237-242.
    posted to acei sarcopenia by jyuh on 2008-06-29 01:46:38 as **
  • Antiproteinuric Response to Dual Blockade of the Renin-Angiotensin System in Primary Glomerulonephritis: Meta-analysis and Metaregression
    American Journal of Kidney Diseases, Vol. In Press, Corrected Proof
    by Fausta Catapano, Paolo Chiodini, Luca D Nicola, Roberto Minutolo, Pasquale Zamboli, Ciro Gallo, Giuseppe Conte
    posted to acei arb dual gn by jyuh on 2008-05-16 14:35:34 as **
  • Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.
    Journal of hypertension, Vol. 25, No. 5. (May 2007), pp. 951-958.
    posted to acei arb bp cv by jyuh on 2008-07-21 02:08:23 as **
  • ACE inhibitors for sarcopenia--as good as exercise training?
    Age and ageing (30 May 2008)
    by Miles D D Witham, Deepa Sumukadas, Marion E T E McMurdo
    posted to acei sarcopenia by jyuh on 2008-06-29 01:06:34 as **
  • Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers
    Nephrol. Dial. Transplant. (8 May 2008), gfn239.
    by Tomas Berl
    posted to acei arb ckd by jyuh on 2008-05-09 04:36:33 as **
  • Targeting cardiovascular protection: the concept of dual renin-angiotensin system control.
    Medscape journal of medicine, Vol. 10 Suppl (2008)
    by T Unger, A Jakobsen, J Heroys, A Ralph, T Rees, M Shaw
    posted to acei arb dual by jyuh on 2008-07-21 02:01:04 as **
  • Combination therapy with an Angiotensin-converting enzyme inhibitor and a vitamin d analog suppresses the progression of renal insufficiency in uremic rats.
    J Am Soc Nephrol, Vol. 18, No. 6. (June 2007), pp. 1796-1806.
    posted to acei animal ckd vitamin by jyuh on 2007-08-29 08:22:36 as **
  • Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
    Kidney international, Vol. 70, No. 7. (October 2006), pp. 1318-1324.
    posted to acei hd mortality rct by jyuh on 2008-07-04 14:35:27 as **
  • Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    American heart journal, Vol. 155, No. 5. (May 2008), pp. 791-805.
    posted to acei arb ckd cv by jyuh on 2008-05-22 09:49:36 as **
  • Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials.
    Lancet, Vol. 368, No. 9535. (12 August 2006), pp. 581-588.
    by GR Dagenais, J Pogue, K Fox, ML Simoons, S Yusuf
    posted to acei chf meta-analysis by jyuh on 2007-12-14 14:37:13 as **
  • Treatment of hypertension in patients 80 years of age or older.
    The New England journal of medicine, Vol. 358, No. 18. (1 May 2008), pp. 1887-1898.
    posted to acei aging rct bp by jyuh on 2008-05-06 03:28:08 as **
  • Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis
    Diabetic Medicine, Vol. 24, No. 5. (May 2007), pp. 486-493.
    posted to acei arb dn meta-analysis by jyuh on 2007-07-19 07:26:41 as ** along with 1 person timsenior
  • Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
    Journal of cardiac failure, Vol. 14, No. 3. (April 2008), pp. 181-188.
    posted to acei arb cv dual meta-analysis by jyuh on 2008-07-20 15:06:28 as **
  • Rationale for Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor Treatment and End-Organ Protection in Patients with Chronic Kidney Disease.
    Am J Nephrol, Vol. 28, No. 3. (12 December 2007), pp. 372-380.
    by Robert Toto, Biff F F Palmer
    posted to acei arb ckd dual by jyuh on 2008-01-20 04:16:28 as **
  • Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
    Lancet, Vol. 361, No. 9352. (11 January 2003), pp. 117-124.
    posted to acei arb ckd dual rct by jyuh on 2008-07-21 04:47:08 as **
  • Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, Vol. 9, No. 1. (March 2008), pp. 1-9.
    posted to acei arb bp ccb by jyuh on 2008-07-21 05:49:29 as **
  • Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (17 April 2008)
    by Leszek Tylicki, Przemysław Rutkowski, Marcin Renke, Wojciech Larczyński, Ewa Aleksandrowicz, Wiesława Lysiak-Szydlowska, Bolesław Rutkowski
    posted to acei arb ckd rct by jyuh on 2008-04-29 03:55:18 as **
  • Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study.
    The American journal of clinical nutrition, Vol. 82, No. 2. (August 2005), pp. 428-434.
    posted to acei cv inflammation obesity by jyuh on 2008-06-29 00:51:00 as **
  • WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
    Cochrane Database Syst Rev, No. 1. (2006)
    by HG Lovell
    posted to acei dm proteinuria by jyuh on 2008-02-14 08:43:29 as **
  • ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.
    Cardiovasc Res, Vol. 73, No. 1. (1 January 2007), pp. 237-246.
    by C Ceconi, KM Fox, WJ Remme, ML Simoons, M Bertrand, G Parrinello, C Kluft, A Blann, D Cokkinos, R Ferrari, ,
    posted to acei endothelial-dysfunction rct by jyuh on 2007-12-14 15:00:54 as **
  • Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin Angiotensin System on Proteinuria in Renal Disease.
    Ann Intern Med (5 November 2007)
    by Regina Kunz, Chris Friedrich, Marcel Wolbers, Johannes F E F Mann
    posted to acei arb ckd dual meta-analysis proteinuria by jyuh on 2007-11-09 02:31:07 as ** along with 1 person timsenior
  • ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats
    Am J Physiol Renal Physiol, Vol. 293, No. 4. (1 October 2007), pp. F1083-1092.
    by Julien Allard, Marie Buleon, Eric Cellier, Isabelle Renaud, Christiane Pecher, Francoise Praddaude, Marc Conti, Ivan Tack, Jean-Pierre Girolami
    posted to acei dn ifg1 kinin pdgf tgfb by jyuh on 2007-10-29 04:29:08 as **
  • Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 9, No. 6-7. (l 2007), pp. 594-601.
    by G Keyhan, SF Chen, L Pilote
    posted to acei chf gender by jyuh on 2008-07-21 03:15:54 as **
  • Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure?
    Journal of internal medicine, Vol. 246, No. 5. (November 1999), pp. 503-507.
    posted to acei ckd inflammation by jyuh on 2008-07-05 10:43:49 as **
  • Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    J Am Soc Nephrol, Vol. 17, No. 12 Suppl 3. (December 2006)
    posted to acei adipokine ckd inflammation irs by jyuh on 2008-01-24 04:22:54 as ** along with 1 person yavanna
  • Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 10, No. 2. (February 2008), pp. 157-163.
    by RA Weir, JJ McMurray, M Puu, SD Solomon, B Olofsson, CB Granger, S Yusuf, EL Michelson, K Swedberg, MA Pfeffer,
    posted to acei arb chf dual rct by jyuh on 2008-07-21 04:10:12 as **
  • Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure
    CMAJ, Vol. 178, No. 10. (6 May 2008), pp. 1303-1311.
    by Louise Pilote, Michal Abrahamowicz, Mark Eisenberg, Karin Humphries, Hassan Behlouli, Jack V Tu
    posted to acei aging chf by jyuh on 2008-05-06 03:31:40 as **
  • Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy.
    The Canadian journal of cardiology, Vol. 24, No. 6. (June 2008), pp. 491-496.
    by DM Rabi, N Khan, M Vallee, MA Hladunewich, SW Tobe, L Pilote
    posted to acei arb gender rct by jyuh on 2008-07-20 15:56:27 as **
  • Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Eur J Endocrinol, Vol. 158, No. 3. (1 March 2008), pp. 317-322.
    by Gang Wang, Fernand M Lai, Ka-Bik Lai, Kai-Ming Chow, Bonnie C Kwan, Philip K Li, Cheuk-Chun Szeto
    posted to acei arb dn podocyte urine by jyuh on 2008-03-23 03:26:52 as **
  • Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
    Arch Intern Med, Vol. 167, No. 18. (8 October 2007), pp. 1930-1936.
    by CO Phillips, A Kashani, DK Ko, G Francis, HM Krumholz
    posted to acei arb dual meta-analysis by jyuh on 2007-10-23 03:01:14 as **
  • Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Int J Cardiol, Vol. 121, No. 1. (14 September 2007), pp. 57-61.
    by ME Bertrand, WJ Remme, KM Fox, R Ferrari, ML Simoons,
    posted to acei cad by jyuh on 2007-12-14 14:40:05 as **
  • The COOPERATE trial: a letter of concern.
    Lancet, Vol. 371, No. 9624. (10 May 2008), pp. 1575-1576.
    by R Kunz, M Wolbers, T Glass, JF Mann
    posted to acei arb meta-analysis rct by jyuh on 2008-07-21 05:00:41 as **
  • Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.
    Cancer, Vol. 112, No. 4. (15 February 2008), pp. 748-757.
    posted to acei arb cancer by jyuh on 2008-07-14 11:32:31 as **
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/tag/acei

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.